Live attenuated vaccine against porcine pleuropneumonia

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/102 (2006.01) C07K 14/285 (2006.01) C12N 1/36 (2006.01)

Patent

CA 2505869

The present invention provides a method for obtaining an immunogenic, non haemolytic strain of Actinobacillus pleuropneumoniae which is modified, at least in a segment of the apxIA gene and optionally in a segment of the apxIIA gene that codes a transmembrane domain of the Apx haemolytic and cytolytic exotoxins. It comprises also the strains, and the attenuated live vaccine against porcine pleuropneumonia obtained therewith.

L'invention concerne un procédé permettant d'obtenir une souche immunogène, non hémolytique de Actinobacillus pleuropneumoniae qui est modifiée, au moins dans un segment du gène apxIA et éventuellement dans un segment du gène apxIIA qui code un domaine transmembranaire des exotoxines hémolytiques et cytolytiques Apx. Elle concerne également les souches, et le vaccin atténué vivant contre la pleuropneumonie du porc obtenu avec ces souches.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Live attenuated vaccine against porcine pleuropneumonia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Live attenuated vaccine against porcine pleuropneumonia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live attenuated vaccine against porcine pleuropneumonia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1713651

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.